Ozempic and related drugs now help people lose up to 20% of their body weight with generally manageable side effects. As the price of these drugs drops, even more of our patients will take them.
How are these drugs (GLP-1 agonists) affecting couples and families? What about the self-image, decision-making, and sexual choices of individuals who finally lose weight after years of struggle and failure? How are the mates, children, friends, and co-workers responding to familiar people with suddenly unfamiliar bodies? And how are these slimmer people responding to others’ responses to them?
Not every newly-slim person will revel in the new attention they get at work. Not every couple will easily navigate the de-centering of food in one partner’s life. Not every lifelong-shy person will feel comfortable with the increased encouragement to socialize. Not every marriage will enjoy the melting away of one newly-slim partner’s sexual inhibitions. Not every newly-slim parent will know how to deal with their teenagers’ envy or insecurity. And not every newly-slim person will feel comfortable admitting how they’ve lost all that weight. And what about the loss of identity?
Therapists and healthcare professionals need to address the emotional and systemic effects of these new weight-loss drugs. Rather than waiting for patients to raise these issues, we must be prepared to ask lots of questions about their challenges.
Register Today:
[ Ссылка ]
